Clinical Trial

Maintenance Hormonal Therapy and DLBCL

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
the study aims to detect the benefit of maintenance tamoxifen after achieving CR with conventional immuno-chemotherapy and/or radiotherapy in patients with DLDCL
Trial Details
NCT Number NCT06355401
Lead Sponsor Sohag University
Conditions Diffuse Large B Cell Lymphoma
Enrollment 100 participants
Start Date 2024-04
Primary Completion 2026-03 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2024-04-09